Nhs_choices Bthft Bradford Teaching HospitalsNHS Foundation Trust NHS Choices
  • Text Size

  • Language

    loading

11 - Eye

NICE Technologies Applicable to this BNF Section
TA Number TA Subject Has the recommendation in the TA been implemented in the organisation for example by changes to the local formulary for drugs, procurement of devices or changes to care pathways? (Yes/No/TA Not Applicable to this organisation)
TA301 Diabetic macular oedema - fluocinolone acetonide intravitreal implant (rapid review of TA271)(TA301) Yes
TA298 Choroidal neorevasularisation (pathological myopia)(TA298) Yes
TA297 Vitreomacular traction (TA297) Implementation in progress
TA294 Macular degeneration (wet age-related) - aflibercept (TA294) Yes
TA283 Macular oedema (retinal vein occlusion) - ranibizumab (TA283) Yes
TA274 Macular oedema (diabetic) - ranibizumab (TA274) Yes
TA271
Diabetic macular oedema - fluocinolone acetonide intravitreal implant (TA271)
Replaced by TA301
TA237 Macular oedema (diabetic) - ranibizumab (TA237) Yes
TA229
Macular oedema (retinal vein occlusion) - dexamethasone (TA229)

Yes
TA155
Macular degeneration (age-related) - ranibizumab and pegaptanid (TA155)
Yes
TA68
Macular degeneration (age-related) - photodynamic therapy (TA68)
Yes